Highlights Omeros Corporation

Equities

OMER

US6821431029

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2024 am IST			5-day change	1st Jan Change
3.64 ^USD	-0.82%		+15.56%	+11.31%

01/04	Tranche Update on Omeros Corporation's Equity Buyback Plan announced on April 1, 2024.	CI
01/04	Omeros Corporation announces an Equity Buyback for $50 million worth of its shares.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Omeros Corporation's Equity Buyback Plan announced on April 1, 2024.	02/04	CI
Omeros Corporation announces an Equity Buyback for $50 million worth of its shares.	02/04	CI
Omeros Swings to Q4 Net Loss; Q1 Outlook Set	02/04	MT
Omeros Corporation Provides Earnings Guidance for the First Quarter of 2024	02/04	CI
Omeros Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Omeros Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/04	CI
North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
DRI Healthcare Trust Expands Royalty Entitlement on US Net Sales of Omidria, Updates Deployment and CAGR Guidance	01/02	MT
Omeros Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Omeros Corporation authorizes a Buyback Plan.	09/11	CI
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting	02/11	CI
Novartis drug candidate scores interim win in rare kidney disease trial	30/23/30	RE
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy	16/23/16	CI
Omeros Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/23/09	CI
Omeros Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10	CI
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria	25/23/25	CI
Omeros Receives $6.69 Million Grant From National Institute on Drug Abuse to Treat Cocaine Use Disorder	10/23/10	MT
Omeros Q4 Loss Narrows	14/23/14	MT
Omeros Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
Omeros Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	14/23/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Omeros Corporation

Equities

OMER

US6821431029

Highlights

Filters